← Back to Search

Dual-plane Ultrasound Imaging for Vascular Access Complications

N/A
Waitlist Available
Led By Robert Anderson, APRN, CNP, DNP
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial is testing whether a new ultrasound probe can help place arterial catheters in the operating room.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
First-stick success rate of ultrasound-guided peripheral arterial catheter placement
Secondary outcome measures
Amount of time required for successful arterial catheter cannulation
Number of attempts for successful cannulation
Number of failed attempts for cannulation

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Butterfly iQ+ ultrasound probeExperimental Treatment1 Intervention
Arterial line placement utilizing dual-plane, Butterfly iQ+ ultrasound probe
Group II: Control GroupActive Control1 Intervention
Arterial line placement via standard mechanism; utilization of a single-plane ultrasound probe

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,634 Total Patients Enrolled
1 Trials studying Vascular Access Complications
74 Patients Enrolled for Vascular Access Complications
Robert Anderson, APRN, CNP, DNPPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
200 Total Patients Enrolled

Media Library

Butterfly iQ+ ultrasound probe Clinical Trial Eligibility Overview. Trial Name: NCT05093699 — N/A
Vascular Access Complications Research Study Groups: Control Group, Butterfly iQ+ ultrasound probe
Vascular Access Complications Clinical Trial 2023: Butterfly iQ+ ultrasound probe Highlights & Side Effects. Trial Name: NCT05093699 — N/A
Butterfly iQ+ ultrasound probe 2023 Treatment Timeline for Medical Study. Trial Name: NCT05093699 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to become a participant in this clinical experiment?

"This trial is accepting a total of 150 participants with vascular access complications aged between 18 and 85. To be eligible, patients must require non-emergent ultrasound guided radial arterial catheter placement, while the medical providers involved need to include certified registered nurse anesthetists (CRNA) and attending anesthesia providers as well as trainees."

Answered by AI

What is the current enrollment status for participants in this research?

"According to the data on clinicaltrials.gov, this study is not presently looking for patients; it was initially posted on May 1st 2022 and last updated by June 29th of that year. However, there are 11 other trials currently accepting enrolment applications."

Answered by AI

Is the age demographic for this clinical trial limited to adults younger than 85?

"This clinical trial is welcoming all individuals aged 18 or above and below the age of 85."

Answered by AI
~51 spots leftby Apr 2025